idsMED Singapore Showcases Innovative Solutions at the 19th ASNO Annual Meeting

The 19th Asian Society for Neuro-Oncology (ASNO) Annual Meeting in Singapore brought together global neuro-oncology experts to exchange knowledge and explore innovative treatments on 16-18 August 2024. idsMED Singapore showcased a range of innovative products aimed at improving patient care for those with brain and spinal tumours, fostering collaboration and lasting connections within the neuro-oncology community.
Event News
27 August 2024
Country(s)
iconicon

The 19th Asian Society for Neuro-Oncology (ASNO) Annual Meeting “Coming Together for Our Patients”, was held at the One Farrer Hotel, Singapore from 16 – 18 August 2024. The event, jointly organised by the Singapore Society of Neuro-Oncology (SSNO) and ASNO, provided a platform for regional and international medical professionals, including neurosurgeons, neurologists, oncologists, nurses, medical students, scientists, and radiologists—to converge, exchange knowledge and explore innovative approaches in neuro-oncology.

Before the Main Conference, a Pre-Conference was held on 14 and 15 August 2024 at the National University Hospital, focusing primarily on providing comprehensive updates on managing common neurosurgical conditions.

idsMED Singapore showcased a range of cutting-edge and innovative products related to neuro-oncology, aimed at enhancing the quality of care for patients with brain and spinal tumours.

The idsMED Singapore Field Sales Specialist (FSS) and Medical Specialty Care (MSC) teams, who were present both at the Pre- and Main Conference, took full advantage of the event to share updates on the latest technologies and demonstrate the effectiveness of the products to the participants.

The collaborative environment fostered at the conference enriched the overall experience, creating a comprehensive and engaging atmosphere for participants and industry partners alike, as they forge lasting connections.

About ASNO, SSNO and JSNO

The Asian Society for Neuro-Oncology (ASNO) is a prominent organisation with a global reputation, dedicated to pushing the boundaries of neuro-oncology through cutting-edge research and innovation.

The Singapore Society of Neuro-Oncology (SSNO) is committed to improving the lives of patients with neuro-oncological conditions through research, education, and collaboration, focusing on advancing the field of neuro-oncology within the vibrant landscape of Singapore.

Emphasising active participation and collaboration, a joint session between SSNO and the Japan Society for Neuro-Oncology (JSNO) is scheduled during the ASNO 2024 to share insights, and research advancements, and foster a broader network within the neuro-oncology community.

Save to bookmark
Share

What to read next


idsMED Singapore Advances Paediatric Care at ...
06 March 2025
idsMED Singapore Advances Paediatric Care at the 1st St. Jude-VIVA Paediatric Neurosurgical Oncology Symposium
From 27 February to 2 March 2025, the 19th St. Jude-VIVA Forum brought together global experts in pa...
Event News
idsMED Singapore Empowers Parkinson’s Disea...
06 March 2025
idsMED Singapore Empowers Parkinson’s Disease Warriors with SilverFit Exergaming System
On 28 February 2025, idsMED Singapore’s Ms. Tan Shwu Jing, Senior Solutions Specialist from the In...
Event News
idsMED Singapore Showcases Latest Imaging Sol...
06 March 2025
idsMED Singapore Showcases Latest Imaging Solutions at 3rd NUWoC Masterclass
idsMED Singapore participated in the 3rd NUWoC Masterclass on Genetics and Genomics for the General ...
Event News